Skip to main content

Table 1 Baseline demographic data of subjects with cardiac syndrome X vs. coronary artery disease (status without known diabetes mellitus)

From: Post-challenge insulin concentration is useful for differentiating between coronary artery disease and cardiac syndrome X in subjects without known diabetes mellitus

 

CSX

(N = 92)

CAD

(N = 145)

p

Age (years)

59 ± 11

62 ± 13

0.015

Gender (M/F)

62/30

132/13

<0.001

Hypertension (N) (%)

71 (77%)

134 (92%)

0.002

Systolic blood pressure (mmHg)

125 (114, 135)

128 (117, 141)

0.049

Body mass index (kg/m2)

25.0 (23.9, 27.3)

25.9 (23.7, 28.2)

0.174

Current smoking (N) (%)

51 (55%)

86 (60%)

0.563

Total cholesterol (mg/dl)

185 (165, 209)

165 (143, 193)

<0.001

LDL-C (mg/dl)

107 (91, 122)

90 (74, 112)

<0.001

HDL-C (mg/dl)

48 (43, 58)

43 (38, 51)

<0.001

Triglycerides (mg/dl)

122 (88, 173)

118 (88, 164)

0.960

Adiponectin (μg/ml)

3.7 (1.5, 6.0)

3.6 (1.5, 5.8)

0.583

Leptin (ng/ml)

4.2 (2.3, 8.5)

4.5 (2.8, 8.3)

0.627

Hs-CRP (mg/dl)

0.09 (0.02, 0.25)

0.12 (0.05, 0.26)

0.104

Medication before index admission

Use of statin (N) (%)

13 (14%)

56 (39%)

<0.001

Use of fibrates (N) (%)

2 (2%)

1 (0.7%)

0.689

Use of anti-hypertensive medication (N) (%)

71 (77%)

134 (92%)

0.002

Medication post index admission

   

Use of statin (N) (%)

22 (24%)

100 (69%)

<0.001

  1. Non-normally distributed data are expressed as median (interquartile range, 25th percentile to 75th percentile)
  2. CAD coronary artery disease, CSX cardiac syndrome X, HDL-C high-density lipoprotein cholesterol, Hs-CRP high sensitivity C-reactive protein, LDL-C low-density lipoprotein cholesterol, Statin HMG-CoA reductase inhibitors